Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-26T03:00:14.666Z Has data issue: false hasContentIssue false

1 - Epidemiology and Clinical Presentation in Esophageal Cancer

Published online by Cambridge University Press:  08 August 2009

By
Satvinder S. Mudan  and
Jin-Yong Kang
Edited by
Sheila C. Rankin
Satvinder S. Mudan
Affiliation:
Consultant in Surgical Oncology, Royal Marsden Hospital, London, UK
Jin-Yong Kang
Affiliation:
Consultant Gastroenterologist and Honorary Senior Lecturer, St. George's Hospital, London
Sheila C. Rankin
Affiliation:
Guy's and St Thomas' Hospital
Get access

Summary

Introduction

The esophagus begins at the level of the cricopharyngeus and traverses the length of the neck to pass through the mediastinum. It then pierces the right crus of the diaphragm and after a short abdominal component joins the stomach at the cardia. For descriptive purposes the esophagus is referred to as cervical (∼6 cm), thoracic (∼25 cm), and abdominal (∼4 cm). Surgeons often refer to the esophagus in divisions of one-third, upper, middle, and distal, as this better relates to the operative options in esophagectomy.

Although not as common as cancer of other sites such as prostate, breast, and colorectum, esophageal cancer has a high lethality rate, the incidence being close to the cancer-specific mortality. Thus, in the USA in 2006, esophageal carcinoma was the 15th commonest cancer, with an estimated 14,550 cases, but it had the 8th highest mortality rate, with an estimated 13,770 deaths.

Esophageal cancer is remarkable for its marked variation by geographical region, ethnicity, and gender. There is a greater than tenfold difference in incidence rates between countries with a low incidence, for example, the United States, and those with a high incidence such as high-risk areas in Iran and China. More than 90% of esophageal cancers are either squamous cell carcinomas (SCCs) or adenocarcinomas, with other tumor types such as melanomas, stromal tumors, lymphomas, or neuroendocrine cancers occurring only rarely in the esophagus.

Type
Chapter
Information
Carcinoma of the Esophagus , pp. 1 - 13
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Jemal, A., Siegel, R., Ward, E., et al. Cancer statistics, 2006. CA Cancer J Clin, 56 (2006), 106–30.CrossRefGoogle ScholarPubMed
Holmes, R. and Vaughan, T. L.. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol, 17 (2007), 2–9.CrossRefGoogle ScholarPubMed
Mariette, C., Finzi, L., Piessen, G., et al. Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. World J Surg, 29 (2005), 39–45.CrossRefGoogle ScholarPubMed
Siewert, J. R. and Ott, K.. Are squamous and adenocarcinomas of the esophagus the same disease?Semin Radiat Oncol, 17 (2007), 38–44.CrossRefGoogle ScholarPubMed
Brown, L. M., Hoover, R., Silverman, D., et al. Excess incidence of squamous cell esophageal cancer among US black men: role of social class and other risk factors. Am J Epidemiol, 153 (2001), 114–22.CrossRefGoogle ScholarPubMed
Wabinga, H. R., Parkin, D. M., Wabwire-Mangen, F., and Nambooze, S.. Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997. Br J Cancer, 82 (2000), 1585–92.Google Scholar
Kubo, A. and Corley, D. A.. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer, 95 (2002), 2096–102.CrossRefGoogle ScholarPubMed
Wu, X., Chen, V. W., Ruiz, B., et al. Incidence of esophageal and gastric carcinomas among American Asians/Pacific Islanders, whites, and blacks: subsite and histology differences. Cancer, 106 (2006), 683–92.CrossRefGoogle ScholarPubMed
Keeney, S. and Bauer, T. L.. Epidemiology of adenocarcinoma of the esophagogastric junction. Surg Oncol Clin N Am, 15 (2006), 687–96.CrossRefGoogle ScholarPubMed
Vizcaino, A. P., Moreno, V., Lambert, R., et al. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995. Int J Cancer, 99 (2002), 860–8.CrossRefGoogle ScholarPubMed
Pera, M.. Trends in incidence and prevalence of specialized intestinal metaplasia, Barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg, 27 (2003), 999–1008.CrossRefGoogle ScholarPubMed
Pera, M., Manterola, C., Vidal, O., and Grande, L.. Epidemiology of esophageal adenocarcinoma. J Surg Oncol, 92 (2005), 151–9 (Review).CrossRefGoogle ScholarPubMed
Newnham, A., Quinn, M. J., Babb, P., Kang, J. Y., and Majeed, A.. Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971–1998. Aliment Pharmacol Ther, 17 (2003), 665–76.CrossRefGoogle ScholarPubMed
Pohl, H. and Welch, H. G.. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst, 97 (2005), 142–6.CrossRefGoogle ScholarPubMed
Shaheen, N. J.. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology, 128 (2005), 1554–66 (Review).CrossRefGoogle ScholarPubMed
Lagergren, J.. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?Gut, 54:Suppl. 1 (2005), 1–5 (Review).CrossRefGoogle ScholarPubMed
Kubo, A. and Corley, D. A.. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol, 99 (2004), 582–8.CrossRefGoogle ScholarPubMed
Bollschweiller, E., Wolfgarten, E., Gutschow, C., et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer, 92 (2001), 549–55.3.0.CO;2-L>CrossRefGoogle Scholar
Lord, R. V., Law, M. G., Ward, R. L., et al. Rising incidence of oesophageal adenocarcinoma in men in Australia. J Gastroenterol Hepatol, 13 (1998), 356–62.CrossRefGoogle ScholarPubMed
Newnham, A., Quinn, M. J., Babb, P., Kang, J. Y., and Majeed, A.. Trends in oesophageal and gastric cancer incidence, mortality and survival in England and Wales 1971–1998/1999. Aliment Pharmacol Ther, 17 (2003), 655–64.CrossRefGoogle ScholarPubMed
Devesa, S. S., Blot, W. J., and Fraumeni, J. F.. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer, 83 (1998), 2049–53.3.0.CO;2-2>CrossRefGoogle ScholarPubMed
Thames Cancer Registry. Cancer in South East England 1997 (London: Thames Cancer Registry, 2000).
Botterweck, A. A., Schouten, L. J., Volovics, A., et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol, 29 (2000), 645–54.CrossRefGoogle ScholarPubMed
Wijnhoven, B. P., Louwman, M. W., Tilanus, H. W., and Coebergh, J. W.. Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol, 14 (2002), 115–22.CrossRefGoogle ScholarPubMed
Hansson, L. E., Sparen, P., and Nyren, O.. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer, 54 (1993), 402–7.CrossRefGoogle ScholarPubMed
Powell, J., McConkey, C. C., Gillison, E. W., et al. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer, 102 (2002), 422–7.CrossRefGoogle ScholarPubMed
Younes, M., Henson, D. E., Ertan, A., et al. Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol, 37 (2002), 1359–65.CrossRefGoogle ScholarPubMed
Engel, L. S., Chow, W. H., Vaughan, T. L., et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst, 95 (2003), 1404–13.CrossRefGoogle ScholarPubMed
Farhadi, M., Tahmasebi, Z., Merat, S., et al. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol, 11 (2005), 1200–3.CrossRefGoogle Scholar
Bahmanyar, S. and Ye, W.. Dietary patterns and risk of squamous-cell carcinoma and adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia: a population-based case-control study in Sweden. Nutr Cancer, 54 (2006), 171–8.CrossRefGoogle ScholarPubMed
Boeing, H., Dietrich, T., Hoffman, K., et al. Intake of fruits and vegetables and risk of cancer of the upper aero-digestive tract: the prospective EPIC-study. Cancer Causes Control, 17 (2006), 957–69.CrossRefGoogle ScholarPubMed
Kuwano, H., Kato, H., Miyazaki, T., et al. Genetic alterations in esophageal cancer. Surg Today, 35 (2005), 7–18.CrossRefGoogle ScholarPubMed
Lee, C. H., Lee, J. M., Wu, D. C., et al. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer, 113 (2005), 456–63.CrossRefGoogle ScholarPubMed
DeMeester, S. R. and DeMeester, T. R.. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg, 231 (2000), 303–21 (Review).CrossRefGoogle ScholarPubMed
DeMeester, S. R.. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol, 13 (2006), 12–30.CrossRefGoogle ScholarPubMed
Lagergren, J., Bergstrom, R., Adami, H. O., and Nyren, O.. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med, 133 (2000), 165–75.CrossRefGoogle ScholarPubMed
Lagergren, J. and Jansson, C.. Use of tight belts and risk of esophageal adenocarcinoma. Int J Cancer, 119 (2006), 2464–6.CrossRefGoogle ScholarPubMed
Lagergren, J., Bergstrom, R., and Nyren, O.. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med, 130 (1999), 883–90.CrossRefGoogle ScholarPubMed
Solaymani-Dodaran, M., Logan, R. F., West, J., et al. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut, 53 (2004), 1070–4.CrossRefGoogle ScholarPubMed
Lagergren, J., Bergstrom, R., Lindgren, A., and Nyren, O.. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med, 340 (1999), 825–31.CrossRefGoogle ScholarPubMed
Wu, A. H., Tseng, C. C., and Bernstein, L.. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer, 98 (2003), 940–8.CrossRefGoogle ScholarPubMed
Siewert, J. R. and Stein, H. J.. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg, 85 (1998), 1457–9.Google ScholarPubMed
Siewert, J. R., Feith, M., and Stein, H. J.. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic–anatomic subclassification. J Surg Oncol, 90 (2005), 139–46.CrossRefGoogle ScholarPubMed
Rusch, V. W.. Are cancers of the esophagus, gastroesophageal junction, and cardia one disease, two, or several?Semin Oncol, 31 (2004), 444–9.CrossRefGoogle ScholarPubMed
Shields, H. M., Rosenberg, S. J., Zwas, F. R., et al. Prospective evaluation of multilayered epithelium in Barrett's esophagus. Am J Gastroenterol, 96 (2001), 3268–78.CrossRefGoogle ScholarPubMed
Mueller, J., Werner, M., and Stolte, M.. Barrett's esophagus: Histopathologic definitions and diagnostic criteria. World J Surg, 28 (2004), 148–54.CrossRefGoogle ScholarPubMed
Atherford, P. A. and Jankowski, J. A.. Molecular biology of Barrett's cancer. Best Pract Res Clin Gastroenterol, 20 (2006), 813–27.CrossRefGoogle Scholar
Theisen, J., Stein, H. J., Feith, H., et al. Preferred location for the development of esophageal adenocarcinoma within a segment of intestinal metaplasia. Surg Endosc, 20 (2006), 235–8.CrossRefGoogle ScholarPubMed
Shaheen, N. J.. Should we worry about the length of Barrett's esophagus?Gastrointest Endosc, 62 (2005), 682–5.CrossRefGoogle ScholarPubMed
Jonge, P. J. F., Steyerberg, E. W., Kuipers, E. J., et al. Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol, 101 (2006), 1421–9.CrossRefGoogle ScholarPubMed
Avidan, B., Sonnenberg, A., Schnell, T. G., et al. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol, 7 (2002), 1930–6.CrossRefGoogle Scholar
Gopal, D. V., Lieberman, D. A., Margaret, N., et al. Risk factors for dysplasia in patients with Barrett's esophagus. Dig Dis Sci, 48 (2003), 1537–41.CrossRefGoogle ScholarPubMed
Weston, A. P., Sharma, P., Mathur, S., et al. Risk stratification of Barrett's esophagus: Updated prospective multivariate analysis. Am J Gastroenterol, 99 (2004), 1657–66.CrossRefGoogle ScholarPubMed
Oberg, S., Wenner, J., Johansson, J., et al. Barrett's esophagus. Risk factors for progression to dysplasia and adenocarcinoma. Ann Surg, 242 (2005), 49–54.Google ScholarPubMed
Ried, B. J., Levine, D. S., Longton, G., et al. Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low and high risk patient subsets. Am J Gastroenterol, 95 (2000), 1669–76.Google Scholar
Cameron, A. J.. Epidemiology of columnar lined esophagus and adenocarcinoma. Gastroenterol Clin North Am, 92 (1997), 918–22.Google ScholarPubMed
Singh, P., Taylor, R. H., and Colin-Jones, D. G.. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present. Am J Gastroenterol, 89 (1994), 349–56.Google ScholarPubMed
Oh, D. S., Hagen, J. A., Fein, M., et al. The impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg, 10 (2006), 787–96.CrossRefGoogle ScholarPubMed
Ye, W., Held, M., Lagergren, J., et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst, 96 (2004), 388–96.CrossRefGoogle ScholarPubMed
Kamanger, F., Dawsey, S. M., Blaser, M. J., et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst, 98 (2006), 1432–4.Google Scholar
González, C. A., Jakszyn, P., Pera, G., et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst, 98 (2006), 345–54.CrossRefGoogle Scholar
González, C. A., Pera, G., Agudo, A., et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer, 118 (2006), 2559–66.CrossRefGoogle Scholar
Jakszyn, P. and Gonzalez, C. A.. Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J Gastroenterol, 12 (2006), 4296–303 (Review).CrossRefGoogle ScholarPubMed
Mayne, S. T., Risch, H. A., Dubrow, R., et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev, 10 (2001), 1055–62.Google ScholarPubMed
Vecchia, C., Negri, E., Lagiou, P., and Trichopoulos, D.. Oesophageal adenocarcinoma: a paradigm of mechanical carcinogenesis?Int J Cancer, 102 (2002), 269–70.CrossRefGoogle ScholarPubMed
Chak, A., Lee, T., Kinnard, M. F., et al. Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut, 51 (2002), 323–8.CrossRefGoogle ScholarPubMed
Tew, W. P., Kelsen, D. P., and Ilson, D. H.. Targeted therapies for esophageal cancer. Oncologist, 10 (2005), 590–601.CrossRefGoogle ScholarPubMed
Reavis, K. M., Morris, C. D., Gopal, D. V., et al. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms. Ann Surg, 239 (2004), 849–58.CrossRefGoogle ScholarPubMed
Lagarde, S. M., Kate, F. J. W. ten, Reitsma, J. B., et al. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol, 24 (2006), 4347–55.CrossRefGoogle ScholarPubMed
Lerut, T., Coosemans, W., Decker, G., et al. Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg, 126 (2003), 1121–8.CrossRefGoogle ScholarPubMed
Alexandrou, A., Davis, P. A., Law, S., et al. Squamous cell carcinoma and adenocarcinoma of the lower third of the esophagus and gastric cardia: similarities and differences. Dis Esophagus, 15 (2002), 290–5.CrossRefGoogle ScholarPubMed
Abunasra, H., Lewis, S., Beggs, L., et al. Predictors of operative death after oesophagectomy for carcinoma. Br J Surg, 92 (2005), 1029–33.CrossRefGoogle ScholarPubMed
Lerut, T., Coosemans, W., Decker, G., et al. Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction. Curr Opin Gastroenterol, 22 (2006), 437–41.CrossRefGoogle ScholarPubMed
Koshy, M., Esiashvilli, N., Landry, J. C., et al. Multiple management modalities in esophageal cancer: combined modality management approaches. Oncologist, 9 (2004), 147–59.CrossRefGoogle ScholarPubMed
Stahl, M.. Adjuvant chemoradiotherapy in gastric cancer and carcinoma of the oesophago-gastric junction. Onkologie, 27 (2004), 33–6.Google ScholarPubMed
Malthaner, R. A., Wong, R. K., Rumble, R. B., et al. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med, 2:1 (2004), 35.CrossRefGoogle ScholarPubMed
Greer, S. E., Goodney, P. P., Sutton, J. E., and Birkmeyer, J. D.. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery, 137 (2005), 172–7.CrossRefGoogle ScholarPubMed
Cunningham, D., Allum, W. H., Stenning, S. P., et al. Perioperative chemotherapy versus surgery alone for gastroesophageal cancer. N Engl J Med, 355 (2006), 11–20.CrossRefGoogle ScholarPubMed
Stahl, M., Wilke, H., Stuschke, M., et al. Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer. J Cancer Res Clin Oncol, 131 (2005), 67–72.CrossRefGoogle ScholarPubMed
Korst, R. J., Kansler, A. L., Port, J. L., et al. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma. Ann Thorac Surg, 82 (2006), 480–4.CrossRefGoogle ScholarPubMed
Malthaner, R. A., Collins, S., and Fenlon, D.. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev, 3 (2006), CD001556.Google Scholar
Dellon, E. S. and Shaheen, N. J.. Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival?J Clin Oncol, 23 (2005), 4478–82.CrossRefGoogle ScholarPubMed
Tabernero, J., Macarulla, T., Ramos, F. J., and Baselga, J.. Novel targeted therapies in the treatment of gastric and esophageal cancer. Ann Oncol, 16 (2005), 1740–8.CrossRefGoogle ScholarPubMed
Akilu, M. and Ilson, D. H.. Targeted agents and esophageal cancer – the next step? Semin Radiat Oncol, 17 (2007), 62–9.CrossRefGoogle Scholar
Langer, R., Specht, K., Becker, K., et al. Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma. Clin Cancer Res, 11 (2005), 7462–9.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×